Table 2.
a. Nonadherence (MGLS) | Unadjusted ORs (95% CIs) | Adjusted ORs (95% CIs) * |
No. of medications | 0.97 (0.87–1.08) | 0.96 (0.85–1.07) |
MRCI (cont.) | 0.83 (0.55–1.26) | 0.89 (0.56–1.44) |
PBM (cont.) | 4.02 (1.03–16) | 4.89 (1.02–23.5) |
Having diabetes | 0.37 (0.15–0.91) | 0.36 (0.14–0.89) |
Decision making (cont.) | 1.11 (1.001–1.23) | 1.15 (1.02–1.29) |
Decision-making (cat; score > 50) | 3.29 (1.41–7.69) | 4.56 (1.68–12.35) |
b. Nonadherence (TABS) | Unadjusted ORs (95% CIs) | Adjusted ORs (95% CIs) |
No. of medications | 1.02 (0.91–1.13) | 1.04 (0.92–1.18) |
MRCI (cont.) | 1.003 (0.96–1.05) | 1.01 (0.96–1.06) |
PBM (cont.) | 3.67 (0.84–16.1) | 2.78 (0.53–14.5) |
BMI (≥30 kg/m2) | 2.85 (0.21–2.6) | 3.81 (1.01–14.5) |
API, Autonomy preference index; Cat., categorical; CIs, confidence intervals; Cont., continuous; MGLS, Morisky Green Levine Scale; PBM, Perceived burden of medications; ORs, odds ratios. * Analysis adjusted for age, gender, eGFR, Charlson’s comorbidity index and IADL.